Key facts
- This page summarizes Florian Schonharting's Form 4 filing for GH Research PLC (GHRS).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 09 Sep 2026, 16:02.
Florian Schonharting - 08 Sep 2026 Form 4 Insider Report for GH Research PLC (GHRS)
- Reporting relationship
- Director
- Issuer ticker
- GHRS
- Reported as of
- 08 Sep 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Sep 2026, 16:02:12 UTC
- Prior SEC filing
- 01 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Florian Schonharting
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Florian Schonharting filed Form 4 for GH Research PLC (GHRS) on 09 Sep 2026.
Change
- Previous filing in this sequence was filed on 01 Apr 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001360509
Primary reporting owner
Schonharting Florian
- Relationship
- Director
- Address
- C/O GH RESEARCH PLC, JOSHUA DAWSON HOUSE, DAWSON STREET, DUBLIN, IRELAND
- Signature
- /s/ Florian Schonharting
- Signature date
- 09 Sep 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GHRS
transaction
Derivative
Share Options (Right to Buy)
Award
- Transaction value
- Shares
- +2,303
- Change %
- Price
- $0.000000*
- Shares after
- 2,303
- Date
- 08 Sep 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 2,303
- Exercise price
- $0.0250
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The share options are immediately fully vested, but are not exercisable until September 8, 2028.